FountainVest And Primavera Acquire 25% Of Laobaixing Pharmacy Chain

Li Dongmei
November 29, 2019 — 09:48 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: China chinese CITIC Distribution Economy Fountainvest healthcare insurance investment laobaixing medicine pharmaceutical Primavera Capital Primavera Capital Group Private Equity retail Shanghai stock exchange technology

Related News:

KKR Leads $180 Million Series F Round In Newly-Minted Asian Unicorn Livspace

February 15, 2022 — 03:32

SAIC Injects RMB500 Million In Chinese EV Maker WM Motor

September 12, 2020 — 03:10

Softbank, Hillhouse Back Chinese Zillow-Like Real Estate Platform Shell Zhaofang

March 5, 2020 — 22:27

Cancer Precision Diagnosis Firm 3D Medicines Raises RMB280M

January 6, 2020 — 09:47

CF PharmTech Completes RMB630M Series E Round

January 2, 2020 — 11:02

Chinese EV Start-Up Byton To Close $500M In Series C Round Against Headwinds

September 11, 2019 — 11:56

Chinese O2O Community E-Commerce Platform Huimin Nets $224M

September 10, 2019 — 16:26

Geely Sets Up JV With German Air Taxis Start-Up After Leading Its $55M Series C1 Round

September 9, 2019 — 16:25

Boyu Capital Leads Nearly $300M Series A Round In IDG-Backed Chinese Lodging Brand

September 9, 2019 — 15:29

Franchising and Licensing Asia (FLAsia) 2024